Anxiety, depression and social support across pregnancy in women with a history of recurrent miscarriage: A prospective study

Author(s):  
Jia Qu ◽  
Xue‐ling Weng ◽  
Ling‐ling Gao
Author(s):  
Jia Qu ◽  
Xueling Weng ◽  
Ling-ling Gao

Abstract Background: Women with a history of recurrent miscarriage(RM) are a more vulnerable population, caring for the pregnant women with a history of RM is quite needed. Although evidence suggests an association among anxiety, depression and social support. Yet, it is unclear about changes in and relationships between anxiety, depression and social support among the pregnant women with a history of RM throughout the pregnancy period. The aim of this study was to examine the changes in and relationships among anxiety, depression and social support across three trimesters of pregnancy in Chinese women with a history of RM. Methods: A prospective, longitudinal study was employed. The study was carried out between September 2016 and October 2017 in a teaching hospital in Guangzhou, China. A convenience sample of 166 pregnant women with a history of RM completed the measures at their 6-12, 20-24 and 32-36 gestational weeks. data were collected by a master student with Zung Self-Rating Anxiety Scale, the Edinburgh Postnatal Depression Scale, and the Perceived Social Support Scale. Results: Anxiety decreased from the early pregnancy to late pregnancy while depression first declined from early pregnancy to mid-pregnancy then remained to late pregnancy. Social support increased from early pregnancy to mid-pregnancy and then remained to late pregnancy. There were correlations in anxiety, depression and social support across the three trimesters of pregnancy. Conclusions: Anxiety and depression are highly prevalent in pregnant women with a history of RM, especially in early pregnancy, which merits clinical attention. Social support was an important buffer against anxiety and depression across the pregnancy. Interventions targeting women with RM may improve the health outcomes of women and their children.


2001 ◽  
Vol 35 (1) ◽  
pp. 12-17 ◽  
Author(s):  
Mehmet Aktekin ◽  
Taha Karaman ◽  
Yesim Yigiter Senol ◽  
Sukru Erdem ◽  
Hakan Erengin ◽  
...  

2007 ◽  
Vol 86 (9) ◽  
pp. 1130-1135 ◽  
Author(s):  
Stavros Athanasiou ◽  
Aris Antsaklis ◽  
Gregoria I. Betsi ◽  
Myrtia Sotiropoulou ◽  
Matthew E. Falagas

2021 ◽  
pp. 130-133
Author(s):  
Seema Patel ◽  
A. Z. Nitnaware ◽  
R. T. Pawar ◽  
Ashish Keche ◽  
Tanvi Rekhade

Recently an increase in the incidence of mucormycosis is noticed in COVID-19 cases. The main aim of this study is to present our experience of rhino-orbito-cerebral mucormycosis in COVID-19 patients and thereby aid its early diagnosis and treatment. This is a prospective study of 12 cases diagnosed as Rhino-orbito-cerebral mucormycosis . Presentation of mucormycosis in COVID-19, their temporal association and outcome of treatment was studied. Pre-existing comorbidities were seen in 91.67% patients, Diabetes Mellitus (83.33%). Previous history of COVID-19 infection and treatment for the same in 41.67% cases, concomitant infection in 16.67% and asymptomatic undiagnosed covid (antibodies positive) was detected in 41.67%. All patients showed improvement in general and nasal condition (100%). Early diagnosis is must.


Author(s):  
Michael S. Borofsky ◽  
Vincent G. Bird

This chapter reviews the results of an important observational study seeking to establish how, in individuals without a history of nephrolithiasis, dietary calcium intake is associated with the risk of symptomatic stone disease. The study found that the mean daily dietary calcium intake was lower in the group who formed stones compared to those who did not and that, after adjusting for covariates, high daily dietary calcium intake was strongly associated with decreased risk of stones.


Nutrients ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 1596 ◽  
Author(s):  
Marisa Armeno ◽  
Antonella Verini ◽  
Mariana del Pino ◽  
Maria Beatriz Araujo ◽  
Graciela Mestre ◽  
...  

Introduction: Epilepsy is a neurological disorder characterized by an increased susceptibility to seizures. The ketogenic diet (KD) is currently the most important alternative non-pharmacological treatment. Despite its long history of clinical use, it is not clear how this diet affects longitudinal growth in children. Methods: A prospective study was designed to evaluate growth and nutritional status in 45 children on KD. Growth was assessed by measuring weight, height, and body mass index (BMI). Standard deviation scores (SDS) were calculated for all measurement parameters at KD initiation and at a two-year follow-up. Results: Overall, 45 patients who completed 24 months on KD were enrolled. Median age was 6.6 years (0.8 to 17.3), with a male predominance (n = 23); 74% of the 45 patients were responders on seizure reduction at three months; 26% of patients were non-responders. In our study, using −1 SDS as a cut-off point, growth deceleration was observed in 9% (n: 4) of the patients; however, the nutritional status was maintained or even improved. No correlation with age, sex, or ambulatory status was found. Conclusions: The nutritional follow-up of these patients was helpful to improve overweight and thinness but could not avoid growth deceleration in some of them. These findings confirm that children with refractory epilepsy on KD treatment require careful growth monitoring.


Sign in / Sign up

Export Citation Format

Share Document